Whitcomb & Hess’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Whitcomb & Hess's ABBV Position: Q2 2026 in Review
Whitcomb & Hess reduced its AbbVie (ABBV) stake by 0.26% in Q2 2026, selling an estimated $1.08K and leaving 1,901 shares worth $478K. The position accounts for 0.1% of the portfolio, ranked #41.
Whitcomb & Hess first reported a position in ABBV in Q4 2021 and has held it in 19 quarters since. 2,555 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Whitcomb & Hess held 1,901 shares of AbbVie worth $478K as of Q2 2026.
- Whitcomb & Hess sold 5 AbbVie shares in Q2 2026, an estimated $1.08K.
- AbbVie made up 0.1% of Whitcomb & Hess's portfolio in Q2 2026, its #41 holding.
- Whitcomb & Hess first reported a position in AbbVie in Q4 2021 and has held it in 19 quarters since.
- 2,555 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Whitcomb & Hess's 13F filing for Q2 2026, filed 8 Jul 2026.